DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Eli Lilly - 1 Bansal - 1 Lilly - 1 Carter Gould - 1 Lilly's headwinds - 1 Novo's - 1 Wells Fargo's Bansal - 1 Evan David Seigerman - 1
Top related locs:
Wells Fargo Lilly's Wednesday's
Top related orgs:
Novo Nordisk - 1 Wells - 1 Barclays - 1 Nordisk - 1 BMO Capital Markets - 1 Food and Drug Administration - 1

Search resuls for: "Wells Fargo's Bansal"


2 mentions found


☆ Eli Lilly's second quarter eases Zepbound pricing fears and suggests it's making headway in weight loss race
  + stars: | 2024-08-08 | by ( Christina Cheddar Berk | In | ) www.cnbc.com   time to read: +5 min
Lilly's shares are up more than 7% on the news. LLY YTD mountain Eli Lilly shares year to date. The first followed positive reports from rivals that showed they were making progress in developing their own weight loss drugs . However, sales rose 59% for Mounjaro quarter over quarter and were up 140% for Zepbound as Lilly saw better pricing. Meanwhile, analysts see several events on the horizon that could further boost Lilly's shares in coming months.
Persons: Eli Lilly, Bansal, Lilly, Carter Gould, Lilly's headwinds, Novo's, Wells Fargo's Bansal, Evan David Seigerman, Chris Schott, Schott, Lilly's Organizations: Novo Nordisk, Wells, Barclays, Nordisk, BMO Capital Markets, Food and Drug Administration Locations: Wells Fargo, Lilly's, Wednesday's
☆ EIi Lilly's weight-loss drug is 'much better' than others on the market, says Wells Fargo's Bansal
  + stars: | 2023-05-01 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEIi Lilly's weight-loss drug is 'much better' than others on the market, says Wells Fargo's BansalMohit Bansal, Wells Fargo managing director, joins 'Fast Money' to discuss Eli Lilly's recent stock performance as demand for its weight-loss drugs climb.
0 next >>
Total: 2